(Q39617663)

13 September 2017

title

Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A99226

22 April 2022

Combined modality therapy of Hodgkin's disease.A report on the stanford trials (English)

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

23 November 2022

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

23 November 2022

4

Glatstein EJ

1 reference

13 September 2017

1

Rosenberg SA

1 reference

13 September 2017

H. S. Kaplan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A99226

22 April 2022

C. S. Portlock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A99226

22 April 2022

language of work or name

English

0 references

publication date

1 August 1978

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

23 November 2022

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

23 November 2022

1 reference

13 September 2017

volume

42

1 reference

13 September 2017

issue

2 Suppl

1 reference

13 September 2017

page(s)

991-1000

1 reference

Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy

13 September 2017

cites work

1

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

23 November 2022

2

31

1860

Carbone

1971

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Latent radiation injury of lungs or heart activated by steroid withdrawal

23 November 2022

3

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Hematologic neoplasia in patients treated for Hodgkin's disease

23 November 2022

4

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

23 November 2022

5

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

23 November 2022

6

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Prednisone in MOPP chemotherapy for Hodgkin's disease

23 November 2022

7

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Nonparametric Estimation from Incomplete Observations

23 November 2022

8

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

23 November 2022

9

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

23 November 2022

10

31

1755

Lukes

1971

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report

23 November 2022

11

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

A combined modality approach to the treatment of Hodgkin's disease.Preliminary results of a prospectively randomized clinical trial

23 November 2022

12

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure

23 November 2022

14

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Long term remissions with combined modality therapy for advanced Hodgkin's disease

23 November 2022

15

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy

23 November 2022

17

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Combination chemotherapy and radiotherapy for Hodgkin's disease

23 November 2022

19

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment

23 November 2022

21

1 reference

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

https://api.crossref.org/works/10.1002/1097-0142(197808)42:2+%3C991::AID-CNCR2820420722%3E3.0.CO;2-A

23 November 2022

Identifiers

10.1002/1097-0142(197808)42:2+<991::AID-CNCR2820420722>3.0.CO;2-A

1 reference

13 September 2017

1 reference